This report provides exclusive insights into the COVID-19 impact on the Viral Vector and Plasmid DNA Manufacturing Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Viral Vector and Plasmid DNA Manufacturing Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Viral Vector and Plasmid DNA Manufacturing Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on viral
vector and plasmid DNA manufacturing market provides an in-depth analysis of
segments and sub-segments in the global as well as regional viral vector and plasmid
DNA manufacturing market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional viral vector and plasmid
DNA manufacturing market over the short term as well as long term. The report
is a comprehensive presentation of trends, forecast and dollar values of global
viral vector and plasmid DNA manufacturing market. According to the report, the
global viral vector and plasmid DNA manufacturing market is projected to grow
at a CAGR of 16.2% over the forecast period of 2019-2025.
Market Insight
The rise in incidence rates of cancer is one of the major drivers
that drives the growth of the viral vector and plasmid DNA manufacturing market
across the globe. According to Cancer Research UK, nearly 17 million new cases
of cancer were there in 2018. The four most common types of cancer worldwide
are lung, breast, bowel, and prostate cancers, which account for about 43% of
all new cases. Furthermore, genetic disorders and infectious diseases also fuel
the growth of the market globally. High unmet needs in patients with rare
disorders and raised acceptance for comparatively newer treatment options in
developing countries are expected to boost the viral vector & plasmid DNA
manufacturing market during the forecast period. However, the high cost of gene
therapies may restrain the growth of the market of viral vector & plasmid DNA
manufacturing. Moreover, the untapped potential of emerging countries creates
an opportunity for the growth of the market in the next few years.
In terms of region, the viral vector & plasmid DNA
manufacturing market has been categorized into North America, Europe, Asia-Pacific,
and the Rest of the World. North America is leading the global viral vector and
plasmid DNA manufacturing market and is estimated to dominate the market growth
over the forecast period. This is attributed to the high adoption of viral
vector-based products in the United States. The growing rate of cancer and monogenic
disorders, rich product pipeline, and technological advancements in the region
drives the growth of the viral vector and plasmid DNA manufacturing market in
the North American region. The market in the Asia Pacific is expected to grow
at a rapid speed over the forecast period. This is attributed to the increased
research initiatives in countries like India and the availability of approved
gene therapies based on viral vectors in countries such as China and Japan.
Segment Covered
The report on global viral vector and plasmid DNA manufacturing
market covers segments such as type, application, disease, and end-user. On the
basis of type, the sub-markets include adenovirus, lentivirus, adeno-associated
virus, plasmid DNA, and other type. On the basis of application, the
sub-markets include gene therapy, vaccinology, and other applications. On the
basis of disease, the sub-markets include cancer, genetic disorders, infectious
disease, and other disease. On the basis of end-user, the sub-markets include
biotech companies, and research institutes.
Companies Profiled:
The report provides profiles of the companies in the market such
as CobraBiologics, Novasep Inc., Cell and Gene Therapy Catapult, Kaneka
Eurogentec S.A., FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics,
Inc., Merck KGaA, uniQure N.V., and Lonza.
Report Highlights:
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of viral vector and
plasmid DNA manufacturing market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.